Aiyegbusi O, McGregor L, McGeoch L, Kipgen D, Geddes CC, Stevens KI. Renal disease in primary Sjögren’s syndrome. Rheumatol Ther. 2021;8(1):63–80. https://doi.org/10.1007/s40744-020-00264-x

Article  PubMed  Google Scholar 

Akiyama M, Suzuki K, Yoshimoto K, Yasuoka H, Kaneko Y, Takeuchi T. Peripheral TIGIT + T follicular helper cells that produce high levels of interleukin-21 via OX40 represent disease activity in IgG4-related disease. Front Immunol. 2021;12:651357. https://doi.org/10.3389/fimmu.2021.651357

Article  PubMed  PubMed Central  CAS  Google Scholar 

Alsharidah AS. Diabetes mellitus and diabetic nephropathy: a review of the literature on hemostatic changes in coagulation and thrombosis. Blood Res. 2022;57(2):101–5. https://doi.org/10.5045/br.2022.2021204

Article  PubMed  PubMed Central  CAS  Google Scholar 

Anders H-J, Saxena R, Zhao M-H, Parodis I, Salmon JE, Mohan C. Lupus nephritis. Nat Rev Dis Primers. 2020;6(1):7. https://doi.org/10.1038/s41572-019-0141-9

Article  PubMed  Google Scholar 

Annese T, Tamma R, Ribatti D. Update in TIGIT immune-checkpoint role in cancer. Front Oncol. 2022;12:871085. https://doi.org/10.3389/fonc.2022.871085

Article  PubMed  PubMed Central  CAS  Google Scholar 

Arazi A, Rao DA, Berthier CC, Davidson A, Liu Y, Hoover PJ, et al. The immune cell landscape in kidneys of patients with lupus nephritis. Nat Immunol. 2019;20(7):902–14. https://doi.org/10.1038/s41590-019-0398-x

Article  PubMed  PubMed Central  CAS  Google Scholar 

Asashima H, Mohanty S, Comi M, Ruff WE, Hoehn KB, Wong P et al. PD-1 high CXCR5– CD4+ peripheral helper T (tph) cells promote tissue-homing plasmablasts in COVID-19. medRxiv. 2021:2021.03.13.21253527. https://doi.org/10.1101/2021.03.13.21253527.

Asashima H, Mohanty S, Comi M, Ruff WE, Hoehn KB, Wong P, et al. PD-1highCXCR5-CD4 + peripheral helper T cells promote CXCR3 + plasmablasts in human acute viral infection. Cell Rep. 2023;42(1):111895. https://doi.org/10.1016/j.celrep.2022.111895

Article  PubMed  PubMed Central  CAS  Google Scholar 

Austin K, Janagan S, Wells M, Crawshaw H, McAdoo S, Robson JC. ANCA associated vasculitis subtypes: recent insights and future perspectives. J Inflamm Res. 2022;15:2567–82. https://doi.org/10.2147/JIR.S284768

Article  PubMed  PubMed Central  Google Scholar 

Balistreri CR, Caruso C, Grimaldi MP, Listì F, Vasto S, Orlando V, et al. CCR5 receptor: biologic and genetic implications in age-related diseases. Ann N Y Acad Sci. 2007;1100:162–72.

Article  PubMed  CAS  Google Scholar 

Bansal T, Takou A, Khwaja A. Progressive chronic kidney disease secondary to tubulointerstitial nephritis in primary biliary cirrhosis. Clin Kidney J. 2012;5(5):442–4. https://doi.org/10.1093/ckj/sfs085

Article  PubMed  PubMed Central  Google Scholar 

Barnas JL, Albrecht J, Meednu N, Alzamareh DF, Baker C, McDavid A, et al. B cell activation and plasma cell differentiation are promoted by IFN-λ in systemic lupus erythematosus. J Immunol. 2021;207(11):2660–72. https://doi.org/10.4049/jimmunol.2100339

Article  PubMed  CAS  Google Scholar 

Basta F, Fasola F, Triantafyllias K, Schwarting A. Systemic lupus erythematosus (SLE) therapy: the old and the new. Rheumatol Ther. 2020;7(3):433–46. https://doi.org/10.1007/s40744-020-00212-9

Article  PubMed  PubMed Central  Google Scholar 

Beckers L, Somers V, Fraussen J. IgD-CD27- double negative (DN) B cells: origins and functions in health and disease. Immunol Lett. 2023;255:67–76. https://doi.org/10.1016/j.imlet.2023.03.003

Article  PubMed  CAS  Google Scholar 

Bhargava R, Li H, Tsokos GC. Pathogenesis of lupus nephritis: the contribution of immune and kidney resident cells. Curr Opin Rheumatol. 2023;35(2):107–16. https://doi.org/10.1097/BOR.0000000000000887

Article  PubMed  CAS  Google Scholar 

Biswas S, Bieber K, Manz RA. IL-10 revisited in systemic lupus erythematosus. Front Immunol. 2022;13:970906. https://doi.org/10.3389/fimmu.2022.970906

Article  PubMed  PubMed Central  CAS  Google Scholar 

Bocharnikov AV, Keegan J, Wacleche VS, Cao Y, Fonseka CY, Wang G, et al. PD-1hiCXCR5- T peripheral helper cells promote B cell responses in lupus via MAF and IL-21. JCI Insight. 2019;4(20). https://doi.org/10.1172/jci.insight.130062

Caielli S, Veiga DT, Balasubramanian P, Athale S, Domic B, Murat E, et al. A CD4 + T cell population expanded in lupus blood provides B cell help through interleukin-10 and succinate. Nat Med. 2019;25(1):75–81. https://doi.org/10.1038/s41591-018-0254-9

Article  PubMed  CAS  Google Scholar 

Cargill T, Barnes E, Culver EL. Expansion of a novel subset of PD1 + CXCR5-CD4 + T peripheral helper cells in IgG4-related disease. Clin Transl Gastroenterol. 2020;11(1):e00111. https://doi.org/10.14309/ctg.0000000000000111

Article  PubMed  PubMed Central  Google Scholar 

Chang S, Li X-K. The role of immune modulation in pathogenesis of IgA nephropathy. Front Med. 2020;7:92.

Article  Google Scholar 

Chen D, Tang T-X, Deng H, Yang X-P, Tang Z-H. Interleukin-7 biology and its effects on immune cells: mediator of generation, differentiation, survival, and homeostasis. Front Immunol. 2021;12:747324. https://doi.org/10.3389/fimmu.2021.747324

Article  PubMed  PubMed Central  CAS  Google Scholar 

Chen W, Yang F, Lin J. Tph cells expanded in primary Sjögren’s syndrome. Front Med. 2022;9:900349.

Article  Google Scholar 

Chen X, Wang Y, Huang X, Geng S, Li C, Zeng L, et al. Targeting Bcl-6 prevents sclerodermatous chronic graft-versus-host disease by abrogating T follicular helper differentiation in mice. Int Immunopharmacol. 2023;117:109746. https://doi.org/10.1016/j.intimp.2023.109746

Article  PubMed  CAS  Google Scholar 

Choi J-Y, Ho JH-e, Pasoto SG, Bunin V, Kim ST, Carrasco S, et al. Circulating follicular helper-like T cells in systemic lupus erythematosus: association with disease activity. Arthritis Rheumatol. 2015;67(4):988–99. https://doi.org/10.1002/art.39020

Article  PubMed  PubMed Central  CAS  Google Scholar 

Christophersen A, Lund EG, Snir O, Solà E, Kanduri C, Dahal-Koirala S, et al. Distinct phenotype of CD4 + T cells driving celiac disease identified in multiple autoimmune conditions. Nat Med. 2019;25(5):734–7. https://doi.org/10.1038/s41591-019-0403-9

Article  PubMed  PubMed Central  CAS  Google Scholar 

Crotty S. Follicular helper CD4 T cells (tfh). Annu Rev Immunol. 2011;29(1):621–63.

Article  PubMed  CAS  Google Scholar 

Crow MK. Pathogenesis of systemic lupus erythematosus: risks, mechanisms and therapeutic targets. Ann Rheum Dis. 2023. https://doi.org/10.1136/ard-2022-223741

Article  PubMed  Google Scholar 

Dadson P, Tetteh CD, Rebelos E, Badeau RM, Moczulski D. Underlying kidney diseases and complications for COVID-19: a review. Front Med. 2020;7:600144. https://doi.org/10.3389/fmed.2020.600144

Article  Google Scholar 

Deng X-M, Yan S-X, Wei W. IL-21 acts as a promising therapeutic target in systemic lupus erythematosus by regulating plasma cell differentiation. Cell Mol Immunol. 2015;12(1):31–9. https://doi.org/10.1038/cmi.2014.58

Article  PubMed  CAS  Google Scholar 

Diefenhardt P, Nosko A, Kluger MA, Richter JV, Wegscheid C, Kobayashi Y, et al. IL-10 receptor signaling empowers regulatory T cells to control Th17 responses and protect from GN. J Am Soc Nephrol. 2018;29(7):1825–37. https://doi.org/10.1681/ASN.2017091044

Article  PubMed  PubMed Central